Analyst Information for Grifols S.A.

$ 18.66   0.10 (+0.54%) Volume: 439.36k 4:00 PM EDT Jul 13, 2020
After Hours:  $ 18.66 0.00 (0.00%) Volume: 5.8k 4:20 PM EDT Jul 13, 2020
Consensus Rating Average
Consensus Rating for GRFS is MODERATE BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 2.20
Previous Average Recommendation 2.20
Change in Average Recommendation 0.00
Number of Analysts Reporting 5
Strong Buy
1.0
Current: 2.20
Previous: 2.20
Change: 0.00
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-DRUGS
Number of companies in industry with recommendations 187
Rank Recommendation relative to companies in its industry 123
Ranked 123 in Industry
1187 MED-DRUGS
Analyst Recommendations
Analysts recommending Strong Buy 3
Analysts recommending Moderate Buy 0
Analysts recommending Hold 1
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 1
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 4
Moderate Buy 0 0 0 0
Hold 1 1 2 1
Moderate Sell 0 0 0 0
Strong Sell 1 1 0 0
Mean Rec. 2.20 2.20 1.80 1.40

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.